Record overview
Status and phase
Status: UNKNOWN
Phase: PHASE2
Sponsor: Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
Condition: Neutropenia
NCT01918241
Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Unknown Status Signal
Timeline signals: stale_update_signal | primary_completion_date_past_signal
Results signal: Low Signal
Operational burden: large_enrollment_target_signal | few_sites_large_trial_signal
Stopped reason
Context when available
No stop reason available in the current public record.